Source: International Congress 2018 – Moving lung transplantation forward
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
S. Campos Silva (Lisboa, Portugal), N. Caires (Lisboa, Portugal), V. Caldeira (Lisboa, Portugal), R. Dias Coelho (Lisboa, Portugal), A. Santos (Lisboa, Portugal), T. Lopes (Lisboa, Portugal), P. Calvinho (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), J. Fragata (Lisboa, Portugal). COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation. 2598

Member's Comments

No comment yet.

Related content which might interest you: Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Lung transplantation in alpha 1 antitrypsin deficiency Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Heterogeneity in lung function of PiZZ alpha 1 antitrypsin deficiency: Impact of occupation in predicting disease severity Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Association between alpha 1 antitrypsin and bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy Source: International Congress 2016 – Best abstracts in COPD management Year: 2016